Podcast

Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program

In the first episode of Pharmacy Focus: Oncology Edition, we spoke with Ron Lanton, JD, principal at Lanton Law.

In the first episode of Pharmacy Focus: Oncology Edition, we spoke with Ron Lanton, JD, principal at Lanton Law. Although it is still too early to know how the program differs from private-sector efforts to improve cancer treatments, Lanton said the program has some interesting goals and approaches.

Related Videos
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
Related Content
Close-up of tumor in lungs -- Image credit: Dr_Microbe | stock.adobe.com
October 23rd 2024

Current Targeted Therapy Options in ROS1-Positive NSCLC

Nicole Bentivegna, PharmD, BCOP
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Team of health care professionals -- Image credit: New Africa | stock.adobe.com
October 23rd 2024

The Pharmacist’s Role on the Multiple Myeloma Care Team Can Vary Among Cancer Centers When Treating Patients With Bispecifics

Gillian McGovern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Cancer cells, 3D illustration
October 22nd 2024

Mycosis Fungoides and Sézary Syndrome, Subtypes of Cutaneous T-Cell Lymphoma, Compromise Health-Related Quality of Life in Patients

Luke Halpern, Assistant Editor
Solid tumor -- Image credit: Yuriy | stock.adobe.com
October 22nd 2024

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment

Amir Ali, PharmD, BCOP Phoebe Kim, PharmD Candidate Stacey Cheung, PharmD Candidate Samantha Shi, PharmD, BCOP Harry Shamamian, PharmD, MBA, FACHE Hien Tang, PharmD, BCOP